PPD Stock Forecast, Price & News

PPD's stock was trading at $25.76 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PPD stock has increased by 27.6% and is now trading at $32.88.
View which stocks have been most impacted by COVID-19.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PPD in the last year. There are currently 16 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for PPD.

PPD is scheduled to release its next quarterly earnings announcement on Wednesday, March 3rd 2021.
View our earnings forecast for PPD.

PPD (NASDAQ:PPD) announced its quarterly earnings results on Tuesday, October, 27th. The company reported $0.30 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.15 by $0.15. The firm had revenue of $1.23 billion for the quarter, compared to analyst estimates of $1.17 billion.
View PPD's earnings history.

PPD updated its fourth quarter 2020 After-Hours earnings guidance on Tuesday, October, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.256-1.298 billion, compared to the consensus revenue estimate of $1.15 billion.

16 equities research analysts have issued 1-year price objectives for PPD's stock. Their forecasts range from $20.00 to $42.00. On average, they expect PPD's stock price to reach $34.80 in the next year. This suggests a possible upside of 5.8% from the stock's current price.
View analysts' price targets for PPD.

Some companies that are related to PPD include IQVIA (IQV), Incyte (INCY), Exact Sciences (EXAS), Charles River Laboratories International (CRL), ICON Public (ICLR), Exelixis (EXEL), PRA Health Sciences (PRAH), Syneos Health (SYNH), Medpace (MEDP), BTG (BTGGF), National Research (NRC), Precigen (PGEN), Starpharma (SPHRY), Anavex Life Sciences (AVXL) and Luna Innovations (LUNA).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other PPD investors own include Cisco Systems (CSCO), Alibaba Group (BABA), Johnson & Johnson (JNJ), salesforce.com (CRM), Pfizer (PFE), CVS Health (CVS), Intel (INTC), NVIDIA (NVDA), Raytheon Technologies (RTX) and Verizon Communications (VZ).

(PPD) raised $1.5 billion in an IPO on Thursday, February 6th 2020. The company issued 60,000,000 shares at $24.00-$27.00 per share. Barclays, J.P. Morgan, Morgan Stanley, Goldman Sachs, BofA Securities, Credit Suisse, Jefferies, UBS Investment Bank, Citigroup, Deutsche Bank Securities, Evercore ISI, HSBC, Mizuho Securities, Baird and William Blair served as the underwriters for the IPO and BofA Securities, Credit Suisse, Jefferies, UBS Investment Bank, Citigroup, Deutsche Bank Securities, Evercore ISI, HSBC, Mizuho Securities, Baird, William Blair and Drexel Hamilton were co-managers.

PPD trades on the NASDAQ under the ticker symbol "PPD."

PPD's stock is owned by many different institutional and retail investors. Top institutional shareholders include LGT Capital Partners LTD. (0.06%), Syquant Capital Sas (0.02%), Amalgamated Bank (0.01%), Convergence Investment Partners LLC (0.00%), Dupont Capital Management Corp (0.00%) and Xponance Inc. (0.00%). Company insiders that own PPD stock include Carlyle Group Management LLC, Christopher Fikry, Colin Hill, David Michael Johnston, David S Simmons, Glen Donovan, Jill Pellegrino, Karen Kaucic, Ronald E Garrow and William J Sharbaugh.
View institutional ownership trends for PPD.

PPD stock was sold by a variety of institutional investors in the last quarter, including LGT Capital Partners LTD.. Company insiders that have sold PPD company stock in the last year include Carlyle Group Management LLC, Colin Hill, David Michael Johnston, Glen Donovan, Jill Pellegrino, Karen Kaucic, and Ronald E Garrow.
View insider buying and selling activity for PPD.

PPD stock was purchased by a variety of institutional investors in the last quarter, including Syquant Capital Sas, Amalgamated Bank, Convergence Investment Partners LLC, Dupont Capital Management Corp, Xponance Inc., Nisa Investment Advisors LLC, and NEXT Financial Group Inc. Company insiders that have bought PPD stock in the last two years include Christopher Fikry, David S Simmons, and William J Sharbaugh.
View insider buying and selling activity for PPD.

Shares of PPD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PPD stock can currently be purchased for approximately $32.88.

PPD has a market capitalization of $11.46 billion and generates $4.03 billion in revenue each year. The company earns $47.82 million in net income (profit) each year or $0.98 on an earnings per share basis. PPD employs 23,000 workers across the globe.

The official website for PPD is www.ppdi.com.

PPD's mailing address is 929 NORTH FRONT STREET, WILMINGTON NC, 28401. The company can be reached via phone at 910-251-0081 or via email at [email protected]